Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial’s AD04 for its Phase 3 Trial

pharmafocusasiaFebruary 22, 2019

Tag: Adial Pharmaceuticals , Catalent , addiction medicines , AD04

PharmaSources Customer Service